Inflammation and Cardiovascular Disease: The Future

Despite considerable advances in reducing the global burden of atherosclerotic cardiovascular disease by targeting conventional risk factors, significant residual risk remains, with low-grade inflammation being one of the strongest risk modifiers. Inflammatory processes within the arterial wall or s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalie Arnold, Katharina Lechner, Christoph Waldeyer, Michael D Shapiro, Wolfgang Koenig
Formato: article
Lenguaje:EN
Publicado: Radcliffe Medical Media 2021
Materias:
Acceso en línea:https://doaj.org/article/c298196d799e49f5b196ebfb168e1c33
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!